𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased erythrocyte catechol-O-methyltransferase activity in elderly: relationship to clinical peculiarities in Parkinson's disease?

✍ Scribed by Dr David Maltête; Thibault Edouard; Bruno Mihout; Jean Costentin

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
79 KB
Volume
25
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Catechol-O-methyltransferase inhibitors:
Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease
✍ Jasper Dingemanse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

Apolipoprotein E ϵ4 and catechol-O-methy
Apolipoprotein E ϵ4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: Relationship to dementia and hallucinations
✍ Richard Camicioli; Ali Rajput; Michelle Rajput; Christian Reece; Haydeh Payami; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract We determined whether apolipoprotein E ϵ4 (ApoE4) or catechol‐__O__‐methyltransferase (COMT) genotypes were associated with dementia, hallucinations, Alzheimer's disease pathological findings (AP), or cortical Lewy bodies (CLBs) in autopsy‐confirmed cases of Parkinson's disease (PD). Ou